Related Experiment Video

Updated: Aug 17, 2026

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

[Effect of photooxidation on biological properties of botulinum neurotoxin A]

V A Kolesnikova, I V Shibaeva, K K Ivanov

    Biokhimiia (Moscow, Russia)
    |January 1, 1983
    PubMed

    Insights

    Photooxidation of botulinic neurotoxin A with methylene blue reduces toxicity. Tryptophan oxidation, not histidine, is the primary cause of this detoxication, preserving the neurotoxin's structure.

    Area of Science:

    • Biochemistry
    • Photochemistry
    • Toxicology

    Context:

    • Botulinic neurotoxin A (BoNT/A) is a potent neurotoxin with significant medical and biodefense implications.
    • Photooxidation is a potential method for detoxifying biological agents.
    • Understanding the molecular mechanisms of BoNT/A inactivation is crucial for developing effective countermeasures.

    Purpose:

    • To investigate the effects of photooxidation on botulinic neurotoxin A (BoNT/A) toxicity.
    • To identify the specific molecular modifications responsible for BoNT/A detoxication during photooxidation.
    • To elucidate the role of histidine and tryptophan residues in the photoinactivation process.

    Summary:

    • Photooxidation of botulinic neurotoxin A in the presence of methylene blue leads to a significant decrease in toxicity, potentially achieving complete detoxication.
    • Even at low residual toxicity (1-3%), the neurotoxin's conformation and antigenic properties remain unaltered.
    • While 5-6 histidine residues per molecule are oxidized, evidence suggests tryptophan oxidation is the primary driver of toxicity reduction, correlating with changes in UV absorbance spectra around 280 nm.

    Impact:

    • This research provides critical insights into the molecular mechanisms underlying botulinic neurotoxin A photoinactivation.
    • Findings suggest that targeted modification of tryptophan residues could be a strategy for developing novel detoxifying agents.
    • The study contributes to the understanding of photochemistry's role in neutralizing potent biological toxins.

    More Related Videos

    Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays12:25

    Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

    Published on: March 3, 2014

    A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors14:10

    A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors

    Published on: November 14, 2014

    Related Concept Videos

    Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

    Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

    Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
    Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
    Anticholinesterase Agents: Poisoning and Treatment01:26

    Anticholinesterase Agents: Poisoning and Treatment

    Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
    Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
    Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin01:26

    Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

    Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
    The binding of dantrolene to the RYR1...
    Bioactivation and Tissue Toxicity01:25

    Bioactivation and Tissue Toxicity

    Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
    Botulism01:22

    Botulism

    Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...